[1]吴 宾,杨自更,王 杰,等.双特异性磷酸酶9对低氧性肺动脉高压小鼠心肺损伤的改善作用实验研究[J].陕西医学杂志,2024,(12):1593-1598.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.002]
　WU Bin,YANG Zigeng,WANG Jie,et al.Improvement effects of dual specificity phosphatase 9 on cardiopulmonary injury in mice with hypoxic pulmonary hypertension[J].,2024,(12):1593-1598.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.002]
点击复制

双特异性磷酸酶9对低氧性肺动脉高压小鼠心肺损伤的改善作用实验研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年12期
页码:
1593-1598
栏目:
基础研究
出版日期:
2024-12-05

文章信息/Info

Title:
Improvement effects of dual specificity phosphatase 9 on cardiopulmonary injury in mice with hypoxic pulmonary hypertension
作者:
吴 宾1; 杨自更1; 王 杰2; 魏玉英3; 梁羽薇1; 余 凤4; 张 婧4
(1.新疆军区总医院核医学科,新疆 乌鲁木齐 830099; 2.新疆军区总医院儿科,新疆 乌鲁木齐 830099; 3.新疆军区总医院重症医学科,新疆 乌鲁木齐 830099; 4.新疆军区总医院营养科,新疆 乌鲁木齐 830099)
Author(s):
WU Bin; YANG Zigeng; WANG Jie; WEI Yuying; LIANG Yuwei; YU Feng; ZHANG Jing
(Department of Nuclear Medicine,General Hospital of Xinjiang Military Command,Urumqi 830099,China)
关键词:
低氧性肺动脉高压;  双特异性磷酸酶9;  炎症;  心肌纤维化;  肺动脉重塑;  心功能
Keywords:
Hypoxic pulmonary hypertension;  Dual specificity phosphatase 9;  Inflammation;  Myocardial fibrosis;  Pulmonary artery remodeling;  Heart function
分类号:
R -33
DOI:
DOI:10.3969/j.issn.1000-7377.2024.12.002
文献标志码:
A
摘要:
目的:探讨双特异性磷酸酶9(DUSP9)对低氧性肺动脉高压(HPH)诱导的小鼠心肺损伤中的改善作用。方法:将C57BL/6小鼠60只随机分为对照组(NC组)、HPH组、HPH+空病毒组(HPH+vector组)和HPH+过表达DUSP9组(HPH+DUSP9组),每组15只。采用低压低氧人工舱建立HPH小鼠模型。于模型建立3周前,按分组要求尾静脉注射AAV9腺相关病毒及对照病毒。检测小鼠肺组织DUSP9蛋白表达、右心功能、心肌纤维化、肺血管重塑、血管活性物质水平、肺泡灌洗液炎症因子表达以及相对肺重量。结果:与NC组比较,HPH组和HPH+vector组DUSP9蛋白表达降低,右心室收缩压(RVSP)、右心室前壁厚度(RVAW)、右心室肥厚指数(RVHI)增加,右心室内径(RVID)降低,右心室胶原容积分数(CVF)增加,一氧化氮(NO)、总一氧化氮合酶(t-NOS)和诱导型一氧化氮合酶(iNOS)水平减少,内皮素-1(ET-1)水平增加,远端肺动脉壁厚度比(WT%)和肺动脉壁面积比(WA%)增加,肺泡灌洗液白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-α及相对肺重量增加(均P<0.05)。与HPH组和HPH+vector组比较,HPH+DUSP9组DUSP蛋白表达增加,RVSP、RVAW、RVHI降低,RVID增加,右心室CVF降低,NO、t-NOS和iNOS水平增加,ET-1水平降低,WT%和WA%降低,肺泡灌洗液IL-1β、IL-6、TNF-α及相对肺重量降低(均P<0.05)。结论:过表达DUSP9可降低HPH小鼠肺动脉压力,改善小鼠右心功能、心肌纤维化、肺血管重塑、血管活性物质的动态平衡和肺内炎症水平,DUSP9可能是HPH小鼠心肺损伤的重要保护性分子。
Abstract:
Objective:To explore the improvement effects of dual specificity phosphatase 9(DUSP9)on cardiopulmonary injury in hypoxic pulmonary hypertension(HPH)mice.Methods:Adult male C57BL/6 mice were randomly divided into control group(NC group),HPH group,HPH+vector group and HPH+DUSP9 group.Artificial low oxygen tank is adopted to establish the HPH model in mice.AAV9 adeno-associated virus and control virus were injected into the tail vein 3 weeks before the establishment of the model according to the grouping requirements.DUSP9 protein expression,right ventricular cardiac function,myocardial fibrosis,pulmonary artery remodeling,vasoactive substance level,levels of inflammatory factors in alveolar lavage fluid,and relative lung weight were evaluated.Results:Compared with the NC group,the expression of DUSP9 protein was decreased,RVSP,RVAW,RVHI were increased,RVID was decreased,CVF was increased,NO,t-NOS and iNOS levels were decreased,ET-1 level was increased,WT% and WA% were increased,and levels of IL-1β,IL-6,TNF-α in bronchoalveolar lavage fluid and relative lung weight were increased in the HPH and HPH+vector groups(all P<0.05).Compared with HPH group and HPH+vector group,the expression of DUSP9 protein was increased,RVSP,RVAW,RVHI were decreased,RVID was increased,CVF was decreased,NO,t-NOS and iNOS levels were increased,ET-1 level was decreased,WT% and WA% were decreased,and the levels of IL-1β,IL-6,TNF-α in bronchoalveolar lavage fluid and relative lung weight were decreased in the HPH+DUSP9 group(all P<0.05).Conclusion:Overexpression of DUSP9 can reduce pulmonary artery pressure,improve right heart function,myocardial fibrosis,pulmonary vascular remodeling,dynamic balance of vasoactive substances and lung inflammation in HPH mice.DUSP9 may be an important protective molecule against cardiopulmonary injury in HPH mice.

参考文献/References:

[1] YOUNG J M,WILLIAMS D R,THOMPSON A.Thin air,thick vessels:Historical and current perspectives on hypoxic pulmonary hypertension[J].Front Med(Lausanne),2019,6(1):93.
[2] 王岚,易群.《中国肺动脉高压诊断与治疗指南(2021版)》解读——肺部疾病和(或)低氧所致肺动脉高压[J].中国实用内科杂志,2022,42(1):55-59.
[3] 郭晓燕,毕蓉蓉,张晔敏,等.活血化瘀祛痰法对野百合碱诱导的肺动脉高压大鼠肺血管重构的影响[J].陕西中医,2023,44(1):3-6.
[4] GENG Y,HU Y,ZHANG F,et al.Mitochondria in hypoxic pulmonary hypertension,roles and the potential targets[J].Front Physiol,2023,14(11):1239643.
[5] YE Y,XU Q,WUREN T.Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension[J].Front Immunol,2023,14(3):1162556.
[6] OGOSHI T,TSUTSUI M,KIDO T,et al.Protective role of myelocytic nitric oxide synthases against hypoxic pulmonary hypertension in mice[J].Am J Respir Crit Care Med,2018,198(2):232-244.
[7] 王培东.血府逐瘀汤治疗慢性阻塞性肺疾病急性加重期合并肺动脉高压的临床观察[J].陕西中医,2017,38(6):701-702.
[8] KHOUBAI F Z,GROSSET C F.DUSP9,a dual-specificity phosphatase with a key role in cell biology and human diseases[J].Int J Mol Sci,2021,22(21):1-10.
[9] CHEN K,GORGEN A,DING A,et al.Dual-specificity phosphatase 9 regulates cellular proliferation and predicts recurrence after surgery in hepatocellular carcinoma[J].Hepatol Commun,2021,5(7):1310-1328.
[10] XIA L,WANG H,XIAO H,et al.EEF1A2 and ERN2 could potentially discriminate metastatic status of mediastinal lymph node in lung adenocarcinomas harboring EGFR 19Del/L858R mutations[J].Thorac Cancer,2020,11(10):2755-2766.
[11] 郑婉,杨珊珊,张娜.半乳糖凝集素-3对低氧性肺动脉高压小鼠肺组织氧化应激和纤维化的调节作用及其机制[J].山西医科大学学报,2023,54(6):770-777.
[12] 王蕊,尚粉青,叶玉兰,等.KLF2在肺动脉高压大鼠肺组织中的表达及机制探讨[J].陕西医学杂志,2020,49(8):919-922.
[13] 张婧,文新元,韦红梅,等.MuRF1在低氧性肺动脉高压中的作用及机制[J].心脏杂志,2024,36(1):1-6.
[14] 吴宾,张婧,卫玮,等.PHB2抑制低氧性肺动脉高压小鼠右心室重塑的作用[J].现代生物医学进展,2024,24(1):25-30.
[15] MANDRAS S A,MEHTA H S,VAIDYA A.Pulmonary hypertension:A brief guide for clinicians[J].Mayo Clin Proc,2020,95(9):1978-1988.
[16] 万钧,翟振国.肺动脉高压临床诊治和管理中需要关注的热点问题——基于《2022 ESC/ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读[J].中国全科医学,2023,26(3):255-261.
[17] 高汉华,马伟东,新怡康,等.川芎嗪联合宣肺通络汤治疗肺动脉高压老年患者疗效观察[J].陕西中医,2017,38(8):1003-1005.
[18] SWISHER J W,WEAVER E.The evolving management and treatment options for patients with pulmonary hypertension:Current evidence and challenges[J].Vasc Health Risk Manag,2023,19(1):103-126.
[19] 张婧,卫玮,韦红梅,等.水仙环素对低氧性肺动脉高压大鼠右心室重塑的影响及机制[J].陕西医学杂志,2023,52(7):793-797.
[20] 胡志玲,陈洁,代地林,等.颈动脉窦电刺激对肺动脉高压右心室重塑的影响[J].医学研究杂志,2022,51(12):22-27.
[21] LI Z,HUANG Z,LUO Y,et al.DUSP9 alleviates hepatic ischemia/reperfusion injury by restraining both mitogen-activated protein kinase and IKK in an apoptosis signal-regulating kinase 1-dependent manner[J].Acta Biochim Biophys Sin(Shanghai),2022,54(12):1811-1821.
[22] YE P,XIANG M,LIAO H,et al.Dual-specificity phosphatase 9 protects against nonalcoholic fatty liver disease in mice through ASK1 suppression[J].Hepatology,2019,69(1):76-93.
[23] LI Z,FEI T,ZHANG J,et al.BMP4 signaling acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells[J].Cell Stem Cell,2012,10(2):171-182.
[24] JIANG L,REN L,GUO X,et al.Dual-specificity phosphatase 9 protects against cardiac hypertrophy by targeting ASK1[J].Int J Biol Sci,2021,17(9):2193-2204.
[25] ZHONG Z,LIU Z,ZHENG R,et al.MiR-132-3p modulates DUSP9-dependent p38/JNK signaling pathways to enhance inflammation in the amnion leading to labor[J].Int J Mol Sci,2022,23(3):1-12.

备注/Memo

备注/Memo:
基金项目:新疆维吾尔族自治区自然科学基金资助项目(2023D01C94,2022D01C644); 新疆军区总医院“喀喇昆仑”人才基金资助项目(2022JC002)
更新日期/Last Update: 2024-12-05